drug

evorpacept

1 story · latest Aug 6, 2026

Status: Investigational
Code: ALX148
Trials: 2 registered trials in coverage

Relationships

Developed by Jazz Pharmaceuticals

Developed by ALX Oncology Inc.

Timeline

ALX Oncology posts Q2 2026 results, reaffirms mid-2027 ASPEN-09-Breast readout

Aug 6Quarterly updateALX Oncology Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.